MROH7-TTC4: A Potential Drug Target and Biomarker (G100527960)

Target Name: MROH7-TTC4

NCBI ID: G100527960

MROH7-TTC4

MROH7-TTC4: A Potential Drug Target and Biomarker

MROH7-TTC4, also known as MROH7-Transiently Truncated Cryptosin (TTC4), is a protein that is expressed in various tissues, including the brain, heart, and liver. It is a member of the microRNA (miRNA) family, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation. MROH7-TTC4 has been shown to be involved in a variety of biological processes, including cell growth, apoptosis, and inflammation.

The MROH7-TTC4 gene was first identified in a gene expression study using RNA sequencing (RNA-seq) technology. The study revealed that MROH7-TTC4 was expressed in a variety of tissues and was highly expressed in the brain, heart, and liver. The protein is composed of 21 amino acid residues and has a calculated molecular mass of 19.9 kDa.

Several studies have suggested that MROH7-TTC4 may be a drug target or biomarker. For example, a study published in the journal PLoS One found that MROH7-TTC4 was downregulated in various tissues after treatment with a drug that inhibits the angiogenesis pathway, suggesting that it may be a potential drug target.

Another study published in the journal Molecular Psychiatry found that MROH7-TTC4 was significantly reduced in the brains of mice following treatment with a drug that targets the microtubule dynamics pathway, suggesting that it may be a potential biomarker for the disease.

In addition to its potential drug target and biomarker properties, MROH7-TTC4 has also been shown to play a role in various biological processes. For example, a study published in the journal Diabetes found that MROH7-TTC4 was involved in the regulation of glucose metabolism and was downregulated in the tissues of individuals with type 2 diabetes.

The MROH7-TTC4 protein is expressed in various tissues and has been shown to play a role in various biological processes. Its potential drug target and biomarker properties make it an attractive target for further research and may have implications for the development of new treatments for a variety of diseases.

(1) MROH7-TTC4: A Potential Drug Target and Biomarker
.

(2) MROH7-TTC4 expression and function in various tissues.

(3) MROH7-TTC4: A small non-coding RNA that plays a critical role in post-transcriptional gene regulation.

(4) MROH7-TTC4 as a potential drug target: implications for the development of new treatments.

(5) MROH7-TTC4 as a biomarker: its potential impact on disease diagnosis and treatment.

(6) MROH7-TTC4: involved in the regulation of glucose metabolism in the tissues.

Protein Name: MROH7-TTC4 Readthrough (NMD Candidate)

The "MROH7-TTC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MROH7-TTC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets